Odyssey Therapeutics (ODTX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 23 100 sessions, May 8, 2026 to September 30, 2026
- Largest daily move
- -11.2% close of July 1, 2026
Company Description
Odyssey Therapeutics (NASDAQ: ODTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.1B.
ODTX has declined 8.8% over the past month. The last closing price was $22.22.
This page collects what Stock Titan holds for ODTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Odyssey Therapeutics (ODTX) closed at $22.22 on September 30, 2026. Over the past month, the price has lost 8.8%.
ODTX Metrics & Rankings
Price returns through September 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Odyssey Therapeutics has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include conferences, AI, earnings, IPO, offering. View all ODTX news →
SEC Filings
Odyssey Therapeutics has filed 10 recent SEC filings, including 4 Form 8-K, 2 Form 10-Q, 2 Form SCHEDULE 13G, 2 Form SCHEDULE 13D. The most recent filing was submitted on September 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ODTX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Odyssey Therapeutics (ODTX) currently stands at 2.2 million shares, down 0.0% from the previous reporting period, representing 5.3% of the float. Since May 2026, short interest has increased by 2453.3%.
Days to Cover History
Days to cover for Odyssey Therapeutics (ODTX) currently stands at 10.8 days, down 15.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since May 2026, the figure has increased by 978%. Across the settlements charted above, it has ranged from 1.0 to 18.7 days.
ODTX Company Profile & Sector Positioning
Odyssey Therapeutics (ODTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.